← Back to Search

Neuromodulation

Transcranial Electrical Stimulation for Mal de Debarquement Syndrome

N/A
Waitlist Available
Led By Yoon-Hee Cha, MD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 years
Awards & highlights

Study Summary

This trial will test whether transcranial electrical stimulation can reduce the perception of self-motion in patients with MdDS.

Eligible Conditions
  • Mal de Debarquement Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dizziness Handicap Inventory
Secondary outcome measures
Hospital Anxiety and Depression Scale
Mal de Debarquement Balance Rating Scale
Other outcome measures
Edinburgh Handedness Scale
Empathy Quotient
Functional Activities Scale
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Transcranial Electrical Stimulation-RealExperimental Treatment1 Intervention
The participant will perform real TES. The forms of TES used in this study will include transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), or transcranial random noise stimulation (tRNS). Each stimulation session will last for 20-minutes.
Group II: Transcranial Electrical Stimulation-ShamPlacebo Group1 Intervention
The participant will perform sham TES for 20-minutes. The form of sham TES will depend on the active arm, e.g. if tACS is on the active arm, then the sham tACS will be a different frequency of stimulation. If tDCS is the active arm, then a short ramp up of tDCS followed by a ramp down (about 60-seconds) will be used as the sham arm.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial Electrical Stimulation
2019
Completed Early Phase 1
~20

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,380 Previous Clinical Trials
1,588,742 Total Patients Enrolled
Yoon-Hee Cha, MDPrincipal InvestigatorUniversity of Minnesota
3 Previous Clinical Trials
99 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Plos OneJournal
Double-blind Randomized N-of-1 Trial of Transcranial Alternating Current Stimulation for Mal De Débarquement Syndrome
Cha, Yoon-Hee, Diamond Gleghorn, and Benjamin Chipper Doudican. 2022. “Double-blind Randomized N-of-1 Trial of Transcranial Alternating Current Stimulation for Mal De Débarquement Syndrome”. Edited by Sandra Carvalho. Plos One. Public Library of Science (PLoS). doi:10.1371/journal.pone.0263558.
clinicaltrials.govStudy
Transcranial Electrical Stimulation for Mal de Debarquement Syndrome
2013. "Transcranial Electrical Stimulation for Mal de Debarquement Syndrome". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02540616.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top